AstraZeneca Plc and Gilead Sciences Potential Merger
News spread through the media announcing that AstraZeneca Plc (AZN) has approached Gilead Sciences (GILD) regarding a possible, potential merger. People familiar with the subject (we don’t know who they are) believe that such a merger, if it materializes, would be the highest healthcare business deal on record.
As told, the story recounts that AstraZeneca got in touch with Gilead in May to gauge the firm’s interest in a possible merger. AstraZeneca did not specify the terms of any transaction, and while Gilead was said to discuss the proposed idea, no decisions have been made about the subject. The storytellers added that the firms are not in official talks about the merger.